Methodological bias in cluster randomised trials

Seokyung Hahn(Seoul National University Hospital), Judith Watson(University of York), Suezann Puffer(University of York), David Torgerson(University of York)

BMC Medical Research Methodology

March 2, 2005

10.1186/1471-2288-5-10

Cited by 314

Related Papers

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

|Osteoporosis International|2007|1.2k

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

|The Lancet|2005|976

CONSORT 2025 statement: updated guideline for reporting randomised trials

|BMJ|2025|847

Guidelines for diagnosis and management of osteoporosis

|Osteoporosis International|1997|793

Understanding controlled trials: What are pragmatic trials?

|BMJ|1998|721